Rahim Fawad, Amin Said, Noor Mohammad, Bahadur Sher, Gul Huma, Mahmood Afsheen, Usman Muhammad, Khan Muhammad Asif, Ullah Raza, Shahab Khalid
Internal Medicine, Khyber Girls Medical College, Peshawar, PAK.
Internal Medicine, Hayatabad Medical Complex Peshawar, Peshawar, PAK.
Cureus. 2020 Oct 12;12(10):e10906. doi: 10.7759/cureus.10906.
Objective To determine the mortality of patients with severe COVID-19 in the intensive care unit (ICU) in relation to age, gender, co-morbidities, ventilatory status, and length of stay (LOS). Methods This was a cross-sectional study based on data retrieved for 204 patients admitted to the ICU of Hayatabad Medical Complex, Peshawar, Pakistan, from April to August 2020. Study variables were age, gender, co-morbid conditions, ventilatory status, and length of stay (LOS). The data were analyzed using SPSS version 21 (IBM Corp., Armonk, NY). The independent t-test and the chi-square test were used to compare the means and frequencies of variables. Multivariate regression analysis was used to predict the likelihood of mortality. Results The overall mortality was 77%. Non-invasive ventilation (NIV) was administered to 61.8% of patients. Mortality was higher for invasive mechanical ventilation (IMV) (93.6% vs 66.7%, p<0.001) and for over 60 years (87.3% vs 72.3%, p=0.019). Mortality without co-morbidities was 75.2%. Comparative mortality rates for at least one co-morbidity (79.7%), diabetes mellitus (80.0%), hypertension (100%), diabetes mellitus and hypertension both (87.1%), and chronic obstructive pulmonary disease (75%) were insignificant. The LOS for survivors was longer (8.9±8.9 versus 5.4±5.2 days, p=0.017). The LOS < 24h was associated with higher mortality (85.9% vs 72.9%, p=0.040). On multivariable regression, the likelihood of mortality was high for IMV (7.330, 95% CI 2.667 - 20.143, p<0.001) and elderly (>60 years) patients (2.607, 95%CI 1.063 - 6.394, p=0.036). Mortality decreased with LOS longer than 24h (0.412, 95%CI 0.173 - 0.982, p=0.045). Co-morbidities did not have any effect on mortality. Conclusions Age more than 60 years and IMV were independent risk factors for higher mortality. Longer ICU stay, specifically more than 24 hours, was associated with lower mortality but LOS less than 24 hours might not have a causal relationship with mortality. The odds of survival were not affected by co-morbidities.
目的 确定重症监护病房(ICU)中重症新型冠状病毒肺炎(COVID-19)患者的死亡率与年龄、性别、合并症、通气状态和住院时间(LOS)之间的关系。方法 这是一项横断面研究,基于2020年4月至8月在巴基斯坦白沙瓦哈亚塔巴德医疗中心ICU收治的204例患者的数据。研究变量包括年龄、性别、合并症情况、通气状态和住院时间(LOS)。使用SPSS 21版(IBM公司,纽约州阿蒙克)对数据进行分析。采用独立t检验和卡方检验比较变量的均值和频率。使用多变量回归分析预测死亡可能性。结果 总体死亡率为77%。61.8%的患者接受了无创通气(NIV)。有创机械通气(IMV)患者的死亡率更高(93.6%对66.7%,p<0.001),60岁以上患者的死亡率更高(87.3%对72.3%,p=0.019)。无合并症患者的死亡率为75.2%。至少有一种合并症(79.7%)、糖尿病(80.0%)、高血压(100%)、糖尿病和高血压并存(87.1%)以及慢性阻塞性肺疾病(75%)的比较死亡率无显著差异。幸存者的住院时间更长(8.9±8.9天对5.4±5.2天,p=0.017)。住院时间<24小时与更高的死亡率相关(85.9%对72.9%,p=0.040)。在多变量回归中,IMV患者(7.330,95%置信区间2.667 - 20.143,p<0.001)和老年(>60岁)患者(2.607,95%置信区间1.063 - 6.394,p=0.036)的死亡可能性较高。住院时间超过24小时死亡率降低(0.412,95%置信区间0.173 - 0.982,p=0.045)。合并症对死亡率没有任何影响。结论 60岁以上年龄和IMV是死亡率升高的独立危险因素。在ICU停留时间较长,特别是超过24小时,与较低的死亡率相关,但住院时间少于24小时可能与死亡率没有因果关系。生存几率不受合并症影响。